Reply to the Letter to the editor “Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD”

• Hirokazu Takahashi,
• Keizo Anzai

Affiliations

Hirokazu Takahashi

Division of Metabolism and Endocrinology, Faculty of Medicine Saga University Saga Japan

Keizo Anzai

Division of Metabolism and Endocrinology, Faculty of Medicine Saga University Saga Japan